Related Experiment Videos
Coronary artery deposition of factor VIII-related antigen in ischemic heart disease
Insights
Researchers found increased Factor VIII-related antigen (FVIIIRAg) in the coronary arteries of patients with coronary artery disease (CAD). This suggests FVIIIRAg may play a role in atherosclerosis development.
Area of Science:
- Cardiovascular pathology
- Immunohistochemistry
- Atherosclerosis research
Background:
- Factor VIII-related antigen (FVIIIRAg) is a glycoprotein.
- Its role in coronary artery disease (CAD) pathogenesis is not fully understood.
Purpose of the Study:
- To investigate the presence and localization of FVIIIRAg in the intramural coronary arteries of patients with and without CAD.
- To determine if FVIIIRAg levels correlate with the presence of CAD.
Main Methods:
- Myocardial autopsy sections from 17 CAD patients and 15 controls were analyzed.
- A monospecific FVIIIRAg antibody and peroxidase-immunoperoxidase technique were used for immunostaining.
- FVIIIRAg was quantified using a FVIIIRAg index (FRI) based on staining characteristics.
Main Results:
- Significantly higher mean FRI in CAD patients (55 +/- 11) compared to controls (12 +/- 5) (P < 0.001).
- FVIIIRAg was localized directly within the intramural coronary arteries.
Conclusions:
- Elevated in situ FVIIIRAg in coronary arteries suggests its potential involvement in atherosclerosis.
- Further research is warranted to elucidate the specific mechanisms by which FVIIIRAg contributes to CAD pathogenesis.
Abstract:
This study localized Factor VIII-related antigen (FVIIIRAg) directly in the intramural coronary arteries of patients with coronary artery disease (CAD). Assays were performed on myocardial autopsy sections from 17 patients with and 15 patients without CAD, using a monospecific FVIIIRAg antibody in the peroxidase-immunoperoxidase technic. FVIIIRAg was quantified by a FVIIIRAg index (FRI), as a numerical score based on distribution, thickness, and extension of immunostaining. The mean FRI for the CAD patients was 55 +/- 11 and that for the control patients 12 +/- 5 (P less than 0.001). The increased amounts of in situ FVIIIRAg suggest this glycoprotein may be involved in the pathogenesis of atherosclerosis.